Company intelligence / Profile preview

TransGen Biotech Co., Ltd.

Beijing, Beijing, Chinatransgenbiotech.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Provides a broad portfolio of innovative and cost-effective life science research products including molecular biology reagents, diagnostic kits, antibodies, nucleic acid extraction systems, and instruments. No clinical trial results as it does not develop drugs.

Modalities: Molecular biology reagents and kits (e.g. PCR/RT-PCR/qPCR/qRT-PCR kits)Antibodies (including specific, tag, secondary, fluorescent-labeled)Nucleic acid purification systemsCell culture media and detection toolsNext Generation Sequencing library prep kitsSmall molecules for research use
Industry: Chemicals & Materials

Beyond the preview

Go deeper on TransGen Biotech Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TransGen Biotech Co., Ltd..

Explore the full profile